✦ LIBER ✦

Thalidomide as an emerging immunotherapeutic agent

✍ Scribed by J.Blake Marriott; George Muller; Angus G Dalgleish

Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 145 KB
Volume: 20
Category: Article
ISSN: 0167-5699
DOI: 10.1016/s0167-5699(99)01531-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thalidomide: An antineoplastic agent

✍ Robert J. Amato 📂 Article 📅 2002 🏛 Current Science Inc. 🌐 English ⚖ 357 KB

Levamisole as an immunotherapeutic agent

Levamisole as an immunotherapeutic agent in the treatment of cancer

✍ willem K. Amery 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 556 KB

Thalidomide: an emerging drug in oral mu

Thalidomide: an emerging drug in oral mucosal lesions

✍ K. Mubeen; M. Ahmed Siddiq; V. R. Jigna 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 160 KB

Evaluation of various cytostatic drugs a

Evaluation of various cytostatic drugs as local immunotherapeutic agents

✍ R. J. Scheper; A. Vos; J. Groot; G. H. Boerrigter 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 399 KB

The cytostatic drugs methotrexate, 5-fluorouracil, adriamycin, vincristin, cisplatinum, VP-16 and the newly synthesized, stabile cyclophosphamide-derivative Z-7557, were screened for possible immunopotentiating effects in local chemotherapy. With an in vivo contact sensitivity model in guinea pigs,

Focal adhesion kinase as an immunotherap

Focal adhesion kinase as an immunotherapeutic target

✍ Hiroya Kobayashi; Makoto Azumi; Yuka Kimura; Keisuke Sato; Naoko Aoki; Shoji Kim 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 533 KB

Lanthanum and its rapidly emerging role

Lanthanum and its rapidly emerging role as an anti-carcinogenic agent

✍ Shailendra Kapoor 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB